Thallion's Mandelzys Interview on Shigamabs Drug, June 6

REPLAY VIDEO
Your next video will start in
Pause

Recommended Videos

  • Info

  • Comments

June 6 (Bloomberg) -- Allan Mandelzys, chief executive officer of Thallion Pharmaceuticals Inc., discusses the company's Shigamabs trial drug, which is designed to treat E. coli infections. Mandelzys speaks with Shannon Pettypiece on Bloomberg Television's "InsideTrack." (Source: Bloomberg)

Advertisement

BTV Channel Finder

Channel_finder_loader

ZIP is required for U.S. locations

Bloomberg Television in   change